MX355511B - Suplemento de la dieta materna. - Google Patents

Suplemento de la dieta materna.

Info

Publication number
MX355511B
MX355511B MX2016004756A MX2016004756A MX355511B MX 355511 B MX355511 B MX 355511B MX 2016004756 A MX2016004756 A MX 2016004756A MX 2016004756 A MX2016004756 A MX 2016004756A MX 355511 B MX355511 B MX 355511B
Authority
MX
Mexico
Prior art keywords
supplemention
maternal diet
maternal
diet
trimester
Prior art date
Application number
MX2016004756A
Other languages
English (en)
Inventor
Isolauri Erika
Salminen Seppo
Laitinen Kirsi
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38820318&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX355511(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX355511B publication Critical patent/MX355511B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a el uso de bacterias en la fabricación de una composición para la administración a una mujer por lo menos en el tercer trimestre del embarazo para la prevención de diabetes gestacional, normalización de la concentración de glucosa en plasma y/o aumento de la sensibilidad a la insulina.
MX2016004756A 2007-07-05 2008-07-04 Suplemento de la dieta materna. MX355511B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07111871A EP2011506A1 (en) 2007-07-05 2007-07-05 Supplementation of maternal diet
PCT/EP2008/058640 WO2009004076A2 (en) 2007-07-05 2008-07-04 Supplemention of maternal diet

Publications (1)

Publication Number Publication Date
MX355511B true MX355511B (es) 2018-04-20

Family

ID=38820318

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2014001089A MX338384B (es) 2007-07-05 2008-07-04 Suplemento de la dieta materna.
MX2016004756A MX355511B (es) 2007-07-05 2008-07-04 Suplemento de la dieta materna.
MX2009014157A MX2009014157A (es) 2007-07-05 2008-07-04 Suplemento de la dieta materna.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014001089A MX338384B (es) 2007-07-05 2008-07-04 Suplemento de la dieta materna.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009014157A MX2009014157A (es) 2007-07-05 2008-07-04 Suplemento de la dieta materna.

Country Status (18)

Country Link
US (3) US8658156B2 (es)
EP (3) EP2011506A1 (es)
CN (1) CN101678055B (es)
AU (1) AU2008270285B2 (es)
BR (1) BRPI0814195B1 (es)
CA (1) CA2691721A1 (es)
CL (1) CL2008001993A1 (es)
ES (1) ES2605453T3 (es)
MX (3) MX338384B (es)
MY (1) MY166648A (es)
PH (1) PH12014502353B1 (es)
PL (1) PL2173367T3 (es)
PT (1) PT2173367T (es)
RU (1) RU2464995C2 (es)
TW (1) TW200918082A (es)
UA (1) UA103750C2 (es)
WO (1) WO2009004076A2 (es)
ZA (1) ZA201000839B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6736251B2 (en) 1992-09-04 2004-05-18 Coinstar, Inc. Coin counter and voucher dispensing machine and method
EP2011506A1 (en) 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
US20110189149A1 (en) * 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria
CN104784219A (zh) 2009-06-19 2015-07-22 杜邦营养生物科学有限公司 治疗糖尿病及相关病症的双歧杆菌
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
RU2467757C1 (ru) * 2011-06-03 2012-11-27 Государственное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова (ВМедА) Способ лечения больных детей сахарным диабетом в стадии декомпенсации
CN103889240B (zh) * 2011-10-18 2016-09-14 雀巢产品技术援助有限公司 用于增加胰岛素敏感性和/或降低胰岛素抵抗性的组合物
CA3092318A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
WO2014072771A1 (en) * 2012-11-12 2014-05-15 Compagnie Gervais Danone Lactobacillus rhamnosus strain for reducing body fat accumulation
JP2016501010A (ja) * 2012-11-12 2016-01-18 コンパニ・ジェルベ・ダノンＣｏｍｐａｇｎｉｅ Ｇｅｒｖａｉｓ Ｄａｎｏｎｅ 体重増加及び／又はインスリン抵抗性を低減させるためのラクトバチルスラムノサス株の使用
MX2016006882A (es) * 2013-11-29 2016-08-17 Nestec Sa Nutricion infantil para el mejoramiento en la sensibilidad a la insulina mas adelante en la vida.
WO2015140233A1 (en) * 2014-03-21 2015-09-24 Nestec S.A. Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
MX2017001632A (es) * 2014-08-08 2017-08-10 Nestec Sa Mioinositol y probioticos, y uso de estos.
WO2016020486A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. A combination of myo-inositol and zinc and its use
MX2017001804A (es) * 2014-08-08 2017-04-27 Nestec Sa Mioinositol y uno o mas probioticos y sus usos.
CN106659739B (zh) * 2014-08-08 2021-06-18 雀巢产品有限公司 维生素d和锌的组合产品及其用途
EP3718418A1 (en) * 2014-08-08 2020-10-07 Société des Produits Nestlé S.A. Vitamin b2 and myo-inositol for treating and preventing gestational diabetes
BR112017000978A2 (pt) * 2014-08-08 2017-11-21 Nestec Sa mioinositol e probióticos e usos
PL235592B1 (pl) * 2015-01-25 2020-09-07 Cieciara Mariusz Płynna kompozycja zawierająca źródło żelaza w postaci niejonowej oraz zastosowanie
CN104687047B (zh) * 2015-03-04 2018-08-24 殷忠义 一种孕妇分娩三合一营养组合物及应用
EP3307290B1 (en) 2015-06-11 2020-04-15 Société des Produits Nestlé S.A. Dietary supplement
ES2551053B1 (es) * 2015-07-31 2016-09-06 Fertypharm, S.L. Complemento alimenticio polivitamínico para mujeres embarazadas
SE1650462A1 (en) * 2016-04-05 2017-10-06 Indevex Ab (Publ) A macronutrient composition for use in a method for treatment of gestational diabetes
KR20180049731A (ko) * 2016-11-03 2018-05-11 주식회사 쎌바이오텍 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
JP7092380B2 (ja) * 2016-12-22 2022-06-28 ユニバーシティ オブ オタゴ 妊娠糖尿病を治療又は予防するための乳酸菌の使用
CA3046705A1 (en) 2017-02-10 2018-08-16 Perfect (China) Co., Ltd. Novel probiotics bifidobacteria strains
JP7266580B2 (ja) * 2018-03-23 2023-04-28 森永乳業株式会社 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物
MX2022000215A (es) * 2019-07-11 2022-05-26 Nestle Sa Composiciones alimenticias para controlar el peso.
CN110604749B (zh) * 2019-08-30 2020-08-14 北京农学院 动物双歧杆菌a12及其在控制糖尿病或高血脂症特别是体重增加或肥胖中的应用
RU2747691C1 (ru) * 2020-08-14 2021-05-12 федеральное государственное бюджетное образовательное учреждение высшего образования "Приволжский исследовательский медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО "ПИМУ" Минздрава России) Способ определения риска наличия наследственных болезней обмена веществ (НБО) у новорожденных
CN111955738A (zh) * 2020-08-17 2020-11-20 山西康惠中天医药科技有限公司 一种产妇分娩用的能量补充产品

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4580542B2 (ja) 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
CN1239166C (zh) 2001-11-16 2006-02-01 郭飞融 生物降糖制剂
AU2003215472A1 (en) * 2002-03-28 2003-10-13 Jeremy Burton Lactobacillus iners for the enhancement of urogenital health
UY27893A1 (es) * 2002-07-12 2003-12-31 Bayer Pharmaceuticals Corp Agonistas del receptor (vpac2) del peptido activante de la adenilatociclasa hipofisaria (pacap) y sus metodos de uso farmacologicos
CN1237168C (zh) * 2002-10-30 2006-01-18 食品工业发展研究所 具有降低与同化胆固醇能力的耐酸与耐胆盐乳杆菌分离株
ES2355382T3 (es) * 2003-06-23 2011-03-25 Nestec S.A. Fórmula para lactantes o de continuación.
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US7438933B2 (en) * 2004-12-09 2008-10-21 The Board Of Trustees Of The University Of Arkansas System Maternal multi-nutrient against diabetes-related birth defects
US20060194241A1 (en) * 2005-02-28 2006-08-31 Jan Knol Lactobacillus specific probes
MX2007012697A (es) * 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
US20060233772A1 (en) * 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2011506A1 (en) 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet

Also Published As

Publication number Publication date
US9636369B2 (en) 2017-05-02
MX338384B (es) 2016-04-14
US20100178281A1 (en) 2010-07-15
ZA201000839B (en) 2011-04-28
RU2010103806A (ru) 2011-08-10
EP2173367B1 (en) 2016-10-19
BRPI0814195A2 (pt) 2015-01-27
US20160193262A1 (en) 2016-07-07
AU2008270285A1 (en) 2009-01-08
ES2605453T3 (es) 2017-03-14
WO2009004076A3 (en) 2009-09-24
PH12014502353A1 (en) 2017-07-10
CN101678055A (zh) 2010-03-24
US9308228B2 (en) 2016-04-12
TW200918082A (en) 2009-05-01
US20140127166A1 (en) 2014-05-08
CL2008001993A1 (es) 2009-09-25
CA2691721A1 (en) 2009-01-08
EP2011506A1 (en) 2009-01-07
EP3120858A1 (en) 2017-01-25
RU2464995C2 (ru) 2012-10-27
MY166648A (en) 2018-07-18
PT2173367T (pt) 2017-01-17
EP3120858B1 (en) 2019-02-06
WO2009004076A2 (en) 2009-01-08
US8658156B2 (en) 2014-02-25
UA103750C2 (ru) 2013-11-25
PH12014502353B1 (en) 2017-07-10
EP2173367A2 (en) 2010-04-14
AU2008270285B2 (en) 2014-09-11
CN101678055B (zh) 2014-01-22
MX2009014157A (es) 2010-01-28
BRPI0814195B1 (pt) 2021-01-05
PL2173367T3 (pl) 2017-05-31

Similar Documents

Publication Publication Date Title
MX338384B (es) Suplemento de la dieta materna.
NZ582329A (en) Improving memory in subjects with mini-mental state examination of 24-26
MY149914A (en) Maternal supplement
MX2009009931A (es) Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MY145999A (en) Preventing diseases in infants delivered via caesarean section
MX2013009948A (es) Composiciones de insulina y cromo para el tratamiento y prevencion de diabetes, hipoglucemia y alteraciones relacionadas.
WO2009001787A1 (ja) 補酵素ｑ１０含有組成物
HK1149717A1 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
TR201903494T4 (tr) Sakkarit oligomerleri içeren besin ürünleri.
AR056835A1 (es) Composicion que contiene oligosacaridos
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2010005198A (es) Composiciones liquidas que comprenden valsartan.
NZ630385A (en) Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance
WO2008122439A3 (en) Dr0spiren0ne/17beta-estradi0l regimen, pharmaceutical combination product and kit for performing this regimen
TH158260A (th) การเสริมโภชนาหารมารดา
WO2010115947A3 (en) Prolonged-release alfa-lipoic acid
UA47023U (ru) Способ профилактики преждевременного отслоения нормально расположенной плаценты у женщин с варикозной болезнью
WO2005087216A3 (de) Behandlung von anämischen zuständen durch inhibierung der erythrozytenapoptose
UA37884U (ru) Способ дифференцированного лечения первичного генитального герпеса и профилактики его рецидивов в эпидемических зонах
梁正辉 Talk Returns to the Doctor’s Office
CO6382128A2 (es) Tratamiento de atrofia vaginal en mujeres con riesgo de patologia cardiovascular
MD3987C2 (ro) Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
Shen Isolated Unilateral Pulmonary Agenesis in Adults
Kim et al. S-321: Vitamin D status and associated metabolic factors in North Korea refugees in South Korea
UA43359U (ru) Применение корвитина как средства для профилактики гастропатии, индуцированной диклофенаком натрия